The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Healthcare Realty Trust Inc

NYSE: HR
Last

(U.S.) $33.02

Today's change-0.54 -1.61%
Updated May 26 3:10 PM EDT. Delayed by at least 15 minutes.
 

Healthcare Realty Trust Inc

NYSE: HR
Last

(U.S.) $33.02

Today's change-0.54 -1.61%
Updated May 26 3:10 PM EDT. Delayed by at least 15 minutes.

Healthcare Realty Trust Inc down (U.S.)$0.54

Healthcare Realty Trust Inc is sharply lower today, dropping (U.S.)$0.54 or 1.61% to (U.S.)$33.02. Shares have lost 1.11% over the last five days, but have gained 8.91% over the last year to date. This security has underperformed the S&P 500 by 10.88% during the last year.

Key company metrics

  • Open(U.S.) $33.57
  • Previous close(U.S.) $33.56
  • High(U.S.) $33.58
  • Low(U.S.) $32.95
  • Bid / Ask(U.S.) $33.00 / (U.S.) $33.03
  • YTD % change+8.91%
  • Volume286,341
  • Average volume (10-day)960,021
  • Average volume (1-month)784,364
  • Average volume (3-month)646,352
  • 52-week range(U.S.) $26.66 to (U.S.) $36.60
  • Beta0.34
  • Trailing P/E34.75×
  • P/E 1 year forward52.44×
  • Forward PEG13.11×
  • Indicated annual dividend(U.S.) $1.20
  • Dividend yield3.63%
  • Trailing EPS(U.S.) $0.95
Updated May 26 3:10 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+26.06%

Based on its net profit margin of 26.06%, Healthcare Realty Trust Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue105105104103
Total other revenue--------
Total revenue105105104103
Gross profit67686666
Total cost of revenue38373836
Total operating expense82807876
Selling / general / administrative9998
Research & development--------
Depreciation / amortization34343231
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income23252527
Interest income (expense), net non-operating-14-14-14-15
Gain (loss) on sale of assets234100
Other--------
Income before tax32531212
Income after tax32531212
Income tax, total--------
Net income32521212
Total adjustments to net income--------
Net income before extra. items32531212
Minority interest--0----
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items32531212
Inc. avail. to common incl. extra. items32521212
Diluted net income32521212
Dilution adjustment--------
Diluted weighted average shares116115115105
Diluted EPS excluding extraordinary itemsvalue per share0.280.460.100.12
Dividends per sharevalue per share0.300.300.300.30
Diluted normalized EPSvalue per share0.080.380.100.12